Mark Wiggins

Directeur/Membre du Conseil chez selectION, Inc.

Profil

Mark C.
Wiggins currently works at selectION, Inc., as Director from 2018.
Mr. Wiggins also formerly worked at Schering Corp., as Marketing Director, Zogenix, Inc., as Independent Director from 2011 to 2022, Schering-Plough Corp., as Head-Business Development from 1986 to 1996, Idera Pharmaceuticals, Inc., as Vice President-Marketing from 1986 to 1998, Biogen, Inc., as Executive VP-Corporate & Business Development from 2003 to 2009, TRACON Pharmaceuticals, Inc., as Chief Business Officer from 2018 to 2022, Elcelyx Therapeutics, Inc., as Senior VP-Corporate & Business Development from 2013 to 2015, Johnson & Johnson Innovation - JJDC, Inc., as Principal, IDEC Pharmaceuticals Corp., as Vice President-Marketing & Business Development from 1998 to 2003, Biogen Idec New Ventures, Inc., as Executive Vice President from 1998 to 2008, MPEX Pharmaceuticals, Inc., as Chief Business Officer from 2009 to 2011, and Vaxcyte, Inc., as Chief Business Officer from 2022 to 2025.
Mr. Wiggins received his undergraduate degree from Syracuse University and Masters Business Admin degree from the University of Arizona.

Postes actifs de Mark Wiggins

Sociétés	Poste	Début
selectION, Inc.	Directeur/Membre du Conseil	01/01/2018

Anciens postes connus de Mark Wiggins

Sociétés	Poste	Fin
VAXCYTE, INC.	Corporate Officer/Principal	01/05/2025
TRACON PHARMACEUTICALS, INC.	Investor Relations Contact	30/09/2022
ZOGENIX, INC.	Directeur/Membre du Conseil	07/03/2022
Elcelyx Therapeutics, Inc.	Corporate Officer/Principal	01/03/2015
MPEX Pharmaceuticals, Inc.	Corporate Officer/Principal	01/01/2011